ZYCAN

Zycan

AED1,313 AED1,225 SAVE 7%

✔ Enhances joint lubrication and support.
✔ Promotes cartilage health and recovery.
✔ Alleviates pain from joint diseases.
✔ Modifies disease progression, slows deterioration.
✔ Supports joints post-surgery, aids rehabilitation.

Product Details

Zycan: 

Maintaining healthy, comfortable joints is crucial for an active horse's performance and well-being. Zycan offers a veterinarian-recommended solution for managing and preventing degenerative and traumatic joint disease (DJD) in horses. This innovative injection provides essential support for promoting long-term joint health and mobility, allowing your horse to move freely and confidently.

Zycan: Empowering Healthy Joints for an Active Life

Zycan is a veterinarian-administered medication containing polysulfated glycosaminoglycan (PSGAG) (100 mg/mL). PSGAGs are naturally occurring molecules that play a vital role in joint health:

  • Joint Lubrication and Support: PSGAGs attract and retain fluid within the joint, acting as a lubricant and shock absorber that protects cartilage and promotes smooth movement.
  • Cartilage Health: Zycan stimulates the production of healthy cartilage components, promoting long-term joint health and preventing deterioration.
  • Pain Management: By supporting healthy joint function and reducing inflammation, Zycan can help alleviate pain associated with DJD, improving your horse's comfort.
  • Disease Modification: Unlike traditional pain relievers, Zycan works by modifying the course of DJD, potentially slowing its progression and preventing further damage.

Multifaceted Support for Joint Health

Zycan offers a versatile approach to managing joint health in horses:

  • Prevention: Early intervention with Zycan can help prevent the development of DJD, especially in young, active horses prone to joint stress.
  • Chronic Joint Maintenance: For horses with existing DJD, Zycan provides ongoing support for managing pain and maintaining joint function.
  • Post-Surgical Recovery: After joint surgery, Zycan can promote healing and support healthy joint function during rehabilitation.

Investing in Long-Term Mobility

Zycan empowers veterinarians to offer a proactive approach to joint health management in horses:

  • Performance Horses: By supporting healthy joints and reducing pain, Zycan allows performance horses to train and compete at their best.
  • Active Horses: For all active horses, Zycan can help maintain mobility and comfort, allowing them to enjoy a fulfilling life.
  • Senior Horses: As horses age, their joints become more susceptible to wear and tear. Zycan can help maintain joint health and mobility in older horses.

Important Considerations:

  • Veterinarian Administration: Zycan is a prescription medication administered only by licensed veterinarians. They will determine the appropriate treatment plan based on your horse's age, activity level, and severity of DJD.
  • Safe and Effective: When used as directed by a veterinarian, Zycan has a well-established safety profile for use in horses.
  • Potential Side Effects: As with any medication, there can be potential side effects. Your veterinarian will discuss these with you in detail.
  • Storage: Store Zycan according to your veterinarian's instructions, typically in a cool, dry place (around 20°C or 68°F).

Promoting Mobility and a Happy Horse

Zycan empowers veterinarians to provide a comprehensive solution for supporting healthy joints and promoting long-term mobility in horses. This translates to improved comfort, a more active lifestyle, and ultimately, a happier horse. Schedule an appointment with your veterinarian to discuss if Zycan is the right choice to address your horse's joint health needs.

Please note: While Zycan has a history of successful use, individual product ratings may not be applicable. Trust your veterinarian's expertise when creating a personalized joint health management plan for your horse.

Directions

Please refer to the product label or consult with your veterinarian for specific dosing recommendations.

Composition

Polysulfated Glycosaminoglycan 100 mg/mL